Uniquity One (uni)
Clinical trials sponsored by Uniquity One (uni), explained in plain language.
-
New asthma drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug, solrikitug, in 145 adults with asthma who still have symptoms despite using standard inhalers. The main goal is to see if the drug can lower certain immune cells (eosinophils) in the blood, which are linked to asthma attacks. Participants re…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise for chronic swallowing disorder
Disease control OngoingThis study tests an experimental drug called NSI-8226 (solrikitug) in 184 adults with eosinophilic esophagitis, a condition that causes throat inflammation and trouble swallowing. Participants receive either the drug or a placebo to see if it reduces throat inflammation and impro…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 19, 2026 11:48 UTC